Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Henry Schein is a solutions company for health care. It operates through two segments: health care distribution, and ...

Representative from animal rights group PETA presented evidence alleging licensed jockey Jose Nicasio has been regular ...

An investment fund wants Henry Schein Inc., Long Island’s largest public company by revenue, to shake up its board of ...

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...

Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...

Henry Schein (NASDAQ:HSIC) rose 7.5% amid a report that an activist investor has taken a stake and is pushing for the dental ...

Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building ...

Auburn City Council has approved settlement agreements with Target and Henry Schein Inc. for their roles in the opioid ...

Henry Schein's acquisition could drive growth, but profitability worries linger. Read why HSIC stock is a cautious buy based ...

BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 5.9% during ...

The Acentus transaction follows Henry Schein's acquisition of Shield Healthcare in 2023 and Prism Medical Products in 2021.